Nymox Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2018
March 29, 2019 at 05:21 pm
Nymox Pharmaceutical Corporation announced earnings results for the full year ended December 31, 2018. For the full year, the company announced total revenue was USD 299,000 compared to USD 224,000 a year ago. Operating loss was USD 10.641 million compared to USD 13.235 million a year ago. Net loss was USD 10.594 million compared to USD 13.429 million a year ago. Basic loss per share was USD 0.18 compared to USD 0.26 a year ago.